TrialCurrent radiopharmaceuticals2023

World's First Experience of the Low-Dose Radionuclide Inhalation Therapy in the Treatment of COVID-19-Associated Viral Pneumonia: Phase 1/2 Clinical Trial.

Peter Shegay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.